62 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
RDY Dr. Reddy's Laboratories Ltd $35.7 $5.93B N/A
Article Searches
Zacks Industry Outlook Highlights: AstraZeneca, Bayer, Dr. Reddy's Laboratories, Teva Pharmaceuticals and Adamas Pharmaceuticals http://www.zacks.com/stock/news/295256/zacks-industry-outlook-highlights-astrazeneca-bayer-dr-reddys-laboratories-teva-pharmaceuticals-and-adamas-pharmaceuticals?cid=CS-ZC-FT-295256 Mar 12, 2018 - Zacks Industry Outlook Highlights: AstraZeneca, Bayer, Dr. Reddy's Laboratories, Teva Pharmaceuticals and Adamas Pharmaceuticals
BioMarin's MAA for Phenylketonuria Candidate Gains EU Nod http://www.zacks.com/stock/news/297425/biomarins-maa-for-phenylketonuria-candidate-gains-eu-nod?cid=CS-ZC-FT-297425 Mar 29, 2018 - BioMarin's (BMRN) MAA submission for its pipeline PKU candidate, pegvaliase, gets accepted in the EU. The same is under priority review in the United States with decision awaited this May.
Is First Trust BICK Index Fund (BICK) a Hot ETF Right Now? http://www.zacks.com/stock/news/313109/is-first-trust-bick-index-fund-bick-a-hot-etf-right-now?cid=CS-ZC-FT-313109 Jul 25, 2018 - Smart Beta ETF report for BICK
IMF Predicts Strong GDP Growth for India: Stocks in Focus http://www.zacks.com/stock/news/326912/imf-predicts-strong-gdp-growth-for-india-stocks-in-focus?cid=CS-ZC-FT-326912 Oct 09, 2018 - Strong growth in the Indian economy should aid stocks from this region.
VIVUS (VVUS) Banks on New Drug Pancreaze, Qsymia Lacks Luster http://www.zacks.com/stock/news/345606/vivus-vvus-banks-on-new-drug-pancreaze-qsymia-lacks-luster?cid=CS-ZC-FT-345606 Jan 03, 2019 - Although VIVUS (VVUS) is struggling with its legacy products, promotional initiatives and addition of cash-flow positive assets bode well for the company.
Top-Ranked Sector ETFs & Stocks to Buy for 2019 http://www.zacks.com/stock/news/346758/top-ranked-sector-etfs-stocks-to-buy-for-2019?cid=CS-ZC-FT-346758 Jan 10, 2019 - Investors could be well served by ETFs and stocks from top-ranked sectors.
Top Ranked Momentum Stocks to Buy for March 20th http://www.zacks.com/commentary/362180/top-ranked-momentum-stocks-to-buy-for-march-20th?cid=CS-ZC-FT-362180 Mar 20, 2019 - Top Ranked Momentum Stocks to Buy for March 20th
Supernus' ADHD Candidate Positive in 4th Phase III Study http://www.zacks.com/stock/news/368648/supernus-adhd-candidate-positive-in-4th-phase-iii-study?cid=CS-ZC-FT-368648 Apr 01, 2019 - Supernus (SUPN) releases top-line results from the fourth phase III study on SPN-812 for the treatment of attention deficit hyperactivity disorder.
BioMarin's Vimizim Wins Nod in China for Rare Genetic Malady http://www.zacks.com/stock/news/425808/biomarins-vimizim-wins-nod-in-china-for-rare-genetic-malady?cid=CS-ZC-FT-425808 Jun 06, 2019 - BioMarin's (BMRN) Vimizim gains an NMPA nod in China for addressing patients suffering Morquio A syndrome, an ultra-rare genetic condition.
Teva Reintroduces Generic Depo-Provera Injection in U.S. http://www.zacks.com/stock/news/277080/teva-reintroduces-generic-depo-provera-injection-in-us?cid=CS-ZC-FT-277080 Sep 27, 2017 - Teva (TEVA) announced the reintroduction of the generic equivalent to Depo-Prover Contraceptive Injection 150 mg/mL in the United States.

Pages: 1234567

<<<Page 5>